Samuel L Aitken

Statistics

Publications

Citations

4.3K

H-Index

Active since

2013

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Health Science Center at Houston

University of Houston

University of Pittsburgh

Baylor College of Medicine

Samuel L Aitken is an author at The University of Texas MD Anderson Cancer Center specializing in infectious diseases, antibiotic resistance, and medical microbiology.

ORCID

Publications per year

2013–2024

Publications

Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections

Pranita D. Tamma, Samuel L Aitken, Robert A. Bonomo et al. · Clinical Infectious Diseases · 2023 · 679 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

Pranita D. Tamma, Samuel L Aitken, Robert A. Bonomo et al. · Clinical Infectious Diseases · 2022 · 498 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

Pranita D. Tamma, Samuel L Aitken, Robert A. Bonomo et al. · Clinical Infectious Diseases · 2020 · 427 citations

Life Sciences, Infectious Diseases, Microbiology +17

Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), andPseudomonas aeruginosawith Difficult-to-Treat Resistance (DTR-P. aeruginosa)

Pranita D. Tamma, Samuel L Aitken, Robert A. Bonomo et al. · Clinical Infectious Diseases · 2021 · 392 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa

José M. Munita, Samuel L Aitken, William R. Miller et al. · Clinical Infectious Diseases · 2017 · 142 citations · Full text

Pharmacy, Infectious Diseases, Microbiology +16

1–5 of 59